Triton Considers Acquisition of German Drug Developer Evotec

Reported 13 days ago

Triton Partners is evaluating a takeover bid for Evotec SE after becoming one of its largest shareholders. The acquisition could face challenges due to Evotec's projected negative cash flow and the need for approval to increase its stake beyond 10%. Despite the company's shares dropping 58% this year, Triton's recent investment has sparked significant stock gains. Ongoing discussions may lead to no formal offer being made.

Source: YAHOO

View details

You may also interested in these wikis

Back to all Wikis